- Home
- CHRS vs AOUT Comparison
CHRS vs AOUT Comparison
Compare CHRS & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- AOUT
- Stock Information
- Founded
- CHRS 2010
- AOUT 2020
- Country
- CHRS United States
- AOUT United States
- Employees
- CHRS N/A
- AOUT N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- AOUT Ordnance And Accessories
- Sector
- CHRS Health Care
- AOUT Industrials
- Exchange
- CHRS Nasdaq
- AOUT Nasdaq
- Market Cap
- CHRS 159.2M
- AOUT 133.2M
- IPO Year
- CHRS 2014
- AOUT N/A
- Fundamental
- Price
- CHRS $1.29
- AOUT $8.81
- Analyst Decision
- CHRS Strong Buy
- AOUT Strong Buy
- Analyst Count
- CHRS 4
- AOUT 2
- Target Price
- CHRS $4.51
- AOUT $15.00
- AVG Volume (30 Days)
- CHRS 1.3M
- AOUT 76.2K
- Earning Date
- CHRS 11-05-2025
- AOUT 09-04-2025
- Dividend Yield
- CHRS N/A
- AOUT N/A
- EPS Growth
- CHRS N/A
- AOUT N/A
- EPS
- CHRS 1.55
- AOUT N/A
- Revenue
- CHRS $272,209,000.00
- AOUT $210,381,000.00
- Revenue This Year
- CHRS N/A
- AOUT N/A
- Revenue Next Year
- CHRS $126.00
- AOUT $6.63
- P/E Ratio
- CHRS $0.83
- AOUT N/A
- Revenue Growth
- CHRS 52.33
- AOUT 5.56
- 52 Week Low
- CHRS $0.66
- AOUT $8.10
- 52 Week High
- CHRS $2.43
- AOUT $17.91
- Technical
- Relative Strength Index (RSI)
- CHRS 62.30
- AOUT 39.86
- Support Level
- CHRS $1.26
- AOUT $8.15
- Resistance Level
- CHRS $1.40
- AOUT $10.50
- Average True Range (ATR)
- CHRS 0.08
- AOUT 0.38
- MACD
- CHRS 0.00
- AOUT -0.15
- Stochastic Oscillator
- CHRS 64.52
- AOUT 27.52
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About AOUT American Outdoor Brands Inc.
American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.